Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abdulla Fouad Group is a diversified Saudi business group with operations across industrial, oil and gas, information technology, power and utility, supply chain, real estate, investment, and healthcare. Within healthcare, the group operates businesses including Abdulla Fouad for Medical Supplies and Services (AFMS), Hakeem Labs, and Medical Technology Solutions (MTS), focused on medical device distribution, in vitro diagnostics, laboratory solutions, life science and research products, nuclear medicine, and specialized testing services. The company appears to be primarily a commercial distributor and healthcare services provider rather than a therapeutic drug developer. Its healthcare business serves government and private-sector customers in Saudi Arabia and nearby regional markets, with a broad offering spanning diagnostics, blood bank services, immunology, toxicology, microbiology, and medical and surgical solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abdulla Fouad Group.